Fortuna Mining Corp. Common Shares vs Novavax Inc — how do they compare? Fortuna Mining Corp. Common Shares trades at $10.92 (market cap $3.13B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: Fortuna Mining Corp. Common Shares is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, Fortuna Mining Corp. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortuna Mining Corp. Common Shares for 1 Days and Novavax Inc for 59 Days on average.
| FSM | NVAX | |
|---|---|---|
Market Cap | $3.13B | $1.82B |
Volume | 6,504,680 | 6,198,505 |
Sector | Basic Materials | Health |
52-Week High | $13.66 | $12.56 |
52-Week Low | $7.84 | $6.22 |
Typical Hold Time | 1 Days | 59 Days |
Enterprise Value | $2.75B | $1.39B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Fortuna Mining is a Canadian precious-metals mining company with operations in Latin America and West Africa. It produces gold and silver and conducts exploration activities in several countries.
Read more on FSM →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →